Core Insights - Tian Da Group has announced a dual-driven strategy focusing on "pharmaceutical health + fine phosphorus chemical" to enhance its industrial layout in Yunnan, marking a new phase of collaborative development and upgrade [1][5] Group Strategy - The company plans to deepen its pharmaceutical health industry layout in Yunnan, leveraging the region's unique biological resources as a key support for Tian Da Pharmaceutical's development [3] - Tian Da Pharmaceutical will implement a quality management system called "Tian Da Standard" to ensure product quality from the source of traditional Chinese medicine to the consumer end, with increased systematic investment in local medicinal materials [3] Product Development - The product matrix of Tian Da Pharmaceutical covers critical therapeutic areas such as cardiovascular, pediatrics, respiratory, anti-infection, and anti-tumor, with established brands like "He Gu" and "Tuo Kang" [3] - The company aims to promote high-quality products and services originating from Yunnan to national and global markets through its online and offline health service platform, "Tian Da Pavilion" [3] Phosphorus Chemical Industry - The fine phosphorus chemical sector will also be developed, with plans to invest in high-value-added projects based on the Xundian phosphorus mine, targeting the creation of a billion-level industrial cluster to assist in the transformation and upgrading of Yunnan's local industry [5] Commitment to Health - The chairman emphasized that the motto "Your health is a big deal for Tian Da" reflects the company's commitment to transforming Yunnan's ecological and resource advantages into high-quality health products and industrial momentum [5]
天大集团启动“医药+磷化工”双轮战略 在滇三十年投资逾十亿奠基新发展